Literature DB >> 21373176

Antioxidants and Other Micronutrients in Complementary Oncology.

Uwe Gröber1.   

Abstract

Many patients being treated for cancer use micronutrient supplements, with the intention to complement their cancer treatment or help them cope with the therapy- and disease-associated side effects. The majority are adding antioxidants without the knowledge of the treating physician. There are many concerns that antioxidants might decrease the effectiveness of chemotherapy, but increasing evidence suggests a benefit when antioxidants are added to conventional cytotoxic therapies. However, it is imperative that physicians explore the use of antioxidant and other micronutrient supplements with their cancer patients and educate them about potentially negative as well as potentially beneficial effects.

Entities:  

Year:  2009        PMID: 21373176      PMCID: PMC2942014          DOI: 10.1159/000194972

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  53 in total

Review 1.  Use of antioxidants during chemotherapy and radiotherapy should be avoided.

Authors:  Gabriella M D'Andrea
Journal:  CA Cancer J Clin       Date:  2005 Sep-Oct       Impact factor: 508.702

2.  Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy.

Authors:  Clet Niyikiza; Sharyn D Baker; David E Seitz; Jackie M Walling; Katrina Nelson; James J Rusthoven; Sally P Stabler; Paolo Paoletti; A Hilary Calvert; Robert H Allen
Journal:  Mol Cancer Ther       Date:  2002-05       Impact factor: 6.261

3.  The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients.

Authors:  Y J Hu; Y Chen; Y Q Zhang; M Z Zhou; X M Song; B Z Zhang; L Luo; P M Xu; Y N Zhao; Y B Zhao; G Cheng
Journal:  Biol Trace Elem Res       Date:  1997-03       Impact factor: 3.738

4.  Use of complementary and alternative medicine in cancer patients: a European survey.

Authors:  A Molassiotis; P Fernández-Ortega; D Pud; G Ozden; J A Scott; V Panteli; A Margulies; M Browall; M Magri; S Selvekerova; E Madsen; L Milovics; I Bruyns; G Gudmundsdottir; S Hummerston; A M-A Ahmad; N Platin; N Kearney; E Patiraki
Journal:  Ann Oncol       Date:  2005-02-02       Impact factor: 32.976

5.  Clinical evaluation of prolonged chemotherapy combined with induction of hepatic drug-metabolizing enzymes as an adjuvant for treating patients with gastric cancer.

Authors:  S Fujimoto; M Miyazaki; Y Kitsukawa; K Okui; T Hosaka; S Karaki; S Kawanomoto
Journal:  Jpn J Surg       Date:  1983-11

6.  Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults.

Authors:  Joachim Bleys; Ana Navas-Acien; Eliseo Guallar
Journal:  Arch Intern Med       Date:  2008-02-25

7.  Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy.

Authors:  Krzysztof Sieja; Małgorzata Talerczyk
Journal:  Gynecol Oncol       Date:  2004-05       Impact factor: 5.482

8.  Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancer.

Authors:  Yuichiro Ohe; Yukito Ichinose; Kazuhiko Nakagawa; Tomohide Tamura; Kaoru Kubota; Nobuyuki Yamamoto; Susumu Adachi; Yoshihiro Nambu; Toshio Fujimoto; Yutaka Nishiwaki; Nagahiro Saijo; Masahiro Fukuoka
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

9.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

10.  Wernicke's encephalopathy: an underrecognized and reversible cause of confusional state in cancer patients.

Authors:  Sheng-Han Kuo; J Mathew Debnam; Gregory N Fuller; John de Groot
Journal:  Oncology       Date:  2008-11-19       Impact factor: 2.935

View more
  9 in total

1.  Complementary Methods in Breast Cancer Therapy.

Authors:  Volker Hanf
Journal:  Breast Care (Basel)       Date:  2009-02-20       Impact factor: 2.860

Review 2.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

Review 3.  Commonly used methods of complementary medicine in the treatment of breast cancer.

Authors:  Jutta Hübner; Volker Hanf
Journal:  Breast Care (Basel)       Date:  2013-10       Impact factor: 2.860

Review 4.  The Role of Nutritional Support in Malnourished Patients With Lung Cancer.

Authors:  Agata Kasprzyk; Krzysztof Bilmin; Tomira Chmielewska-Ignatowicz; Jakub Pawlikowski; Urszula Religioni; Piotr Merks
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.406

5.  Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.

Authors:  Andrea Coccia; Luciana Mosca; Rosa Puca; Giorgio Mangino; Alessandro Rossi; Eugenio Lendaro
Journal:  Oncol Rep       Date:  2016-10-05       Impact factor: 3.906

Review 6.  Inhibition of cancer antioxidant defense by natural compounds.

Authors:  Alicja Sznarkowska; Anna Kostecka; Katarzyna Meller; Krzysztof Piotr Bielawski
Journal:  Oncotarget       Date:  2017-02-28

7.  Synthetic and natural antioxidants attenuate cisplatin-induced vomiting.

Authors:  Javaid Alam; Fazal Subhan; Ihsan Ullah; Muhammad Shahid; Gowhar Ali; Robert D E Sewell
Journal:  BMC Pharmacol Toxicol       Date:  2017-01-13       Impact factor: 2.483

Review 8.  Ocoxin as a complement to first line treatments in cancer.

Authors:  Aitor Benedicto; Eduardo Sanz; Joana Márquez
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

9.  An Analysis of the Use of Complementary and Alternative Therapies in Patients with Breast Cancer.

Authors:  Oktay Tarhan; Ugur Muslu; Isil Somali; Cigdem Erten; Ahmet Alacacioglu; Sengul Varol; Leyla Aslan
Journal:  Breast Care (Basel)       Date:  2009-10-01       Impact factor: 2.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.